L. Roy Papp & Associates LLP Purchases 359 Shares of Mettler-Toledo International, Inc. $MTD

Key Points

• L. Roy Papp & Associates LLP increased its stake in Mettler-Toledo by 3.6% during Q2, acquiring an additional 359 shares, bringing its total to 10,242 shares valued at approximately $12 million.
• Several institutional investors have also ramped up their investments, with PineStone Asset Management Inc. leading with a 41.9% increase in holdings during Q2.
• Analysts have raised price targets for Mettler-Toledo, with a consensus target now at $1,336.50 and a majority rating indicating it is a Hold.

L. Roy Papp & Associates LLP grew its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 3.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,242 shares of the medical instruments supplier's stock after acquiring an additional 359 shares during the quarter. Mettler-Toledo International comprises 1.4% of L. Roy Papp & Associates LLP's holdings, making the stock its 19th largest holding. L. Roy Papp & Associates LLP's holdings in Mettler-Toledo International were worth $12,031,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the stock. Vanguard Group Inc. grew its holdings in Mettler-Toledo International by 1.2% during the first quarter. Vanguard Group Inc. now owns 2,543,365 shares of the medical instruments supplier's stock worth $3,003,485,000 after buying an additional 30,535 shares in the last quarter. Alliancebernstein L.P. grew its holdings in Mettler-Toledo International by 21.6% during the first quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier's stock worth $837,653,000 after buying an additional 126,147 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in Mettler-Toledo International by 5.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier's stock worth $568,032,000 after buying an additional 25,272 shares in the last quarter. T. Rowe Price Investment Management Inc. grew its holdings in Mettler-Toledo International by 11.9% during the first quarter. T. Rowe Price Investment Management Inc. now owns 406,189 shares of the medical instruments supplier's stock worth $479,673,000 after buying an additional 43,082 shares in the last quarter. Finally, PineStone Asset Management Inc. grew its holdings in Mettler-Toledo International by 41.9% during the second quarter. PineStone Asset Management Inc. now owns 334,349 shares of the medical instruments supplier's stock worth $392,766,000 after buying an additional 98,737 shares in the last quarter. Institutional investors own 95.07% of the company's stock.

Analyst Ratings Changes

Several brokerages recently issued reports on MTD. JPMorgan Chase & Co. upped their price target on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a "neutral" rating in a report on Thursday. Bank of America boosted their price objective on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a "neutral" rating in a research report on Monday, September 22nd. Robert W. Baird boosted their price objective on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a "neutral" rating in a research report on Monday, August 4th. Evercore ISI boosted their price objective on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an "outperform" rating in a research report on Tuesday. Finally, Weiss Ratings reissued a "hold (c)" rating on shares of Mettler-Toledo International in a research report on Wednesday. Five investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat.com, Mettler-Toledo International currently has a consensus rating of "Hold" and a consensus price target of $1,336.50.

Mettler-Toledo International Price Performance

Shares of NYSE MTD opened at $1,307.98 on Friday. Mettler-Toledo International, Inc. has a one year low of $946.69 and a one year high of $1,486.76. The business's fifty day moving average price is $1,277.46 and its 200-day moving average price is $1,189.50. The stock has a market capitalization of $26.94 billion, a PE ratio of 33.12, a P/E/G ratio of 3.99 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, beating analysts' consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The firm had revenue of $983.22 million for the quarter, compared to analysts' expectations of $957.41 million. During the same quarter in the prior year, the firm earned $9.65 EPS. The business's revenue for the quarter was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, equities analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Gerry Keller sold 165 shares of the stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the sale, the insider owned 94 shares of the company's stock, valued at approximately $123,012.16. This represents a 63.71% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Thomas P. Salice sold 1,062 shares of the stock in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the sale, the director directly owned 283 shares in the company, valued at $368,154.70. This trade represents a 78.96% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 1,827 shares of company stock valued at $2,371,208. Corporate insiders own 1.94% of the company's stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.